Schedule 13G ownership disclosure

BENITEC BIOPHARMA INC

Security class unavailable · CUSIP: 08205P100

Event date: 2022-09-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,000,000
Percent of class
3.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-107022
Form type
SC 13G/A
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Oct 07, 2022
Reporting period
Sep 14, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub